Pathogenic mutations in many of these genes (such as DRD2, GNAL, GNAO1, ADCY5, and PDE10A) have been identified in patients with movement disorders (such as dystonia and dyskinesia) [6–11]. Here, GNAO1 is linked to movement disorder.